Most of these inhibitors showed similar cell protections at 3 μM, 30 μM, and 300 nM (Table 2), suggesting possible interactions of these inhibitors at high concentrations with other off-targets in the Sp2 mouse myeloma cells. Here, SP2 is linked to plasma cell myeloma.